Michael S. Balzer

MD FASN | Nephrologist | #ClinScientist | Ed. board @JASN_News | #SingleCell | Determined to understand adaptation to kidney disease | #ERCStG

[Michael S. Balzer @ms_balzer]

For anyone coming from X:
Official BALZER LAB account is now at🦋
👉 https://t.co/6x9UrLr4fC

[Michael S. Balzer @ms_balzer]

Alright, #MedTwitter #NephTwitter 🫘 The time has come to move on... Would love to stay in touch! Find me at 🦋 https://t.co/MKbnp4Lpc8

[Michael S. Balzer @ms_balzer]

Alright, #MedTwitter #NephTwitter 🫘 The time has come to move on... Would love to stay in touch! Find me at 🦋 https://t.co/MKbnp4Lpc8

[NEJM @NEJM]

Original Article: Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease (EMPA-KIDNEY) https://t.co/yVvVg7V37b

#KidneyWk | @ASNKidney

[Michael S. Balzer @ms_balzer]

Amazing new spatial data in DKD (1.7M cells) from @BernhardDumoul1 @KSusztak lab #kidneyweek2024

[Michael S. Balzer @ms_balzer]

Instrumental work by Hiroaki Kikuchi from @MarkKnepper6 lab on what instigates renal compensatory growth #kidneyweek2024

[Michael S. Balzer @ms_balzer]

Fantastic talk by @MiguelCheSoares on labile heme and Host-Microbe interactions in the context of AKI #KidneyWk2024

[Michael S. Balzer @ms_balzer]

Want to know how to extend your kidneys’ lifespan? Starting off “Opposing Demands in Kidney Injury: How to Adapt” with Martin Späth leveraging caloric restriction for kidney injury. #kidneyweek2024

[Michael S. Balzer @ms_balzer]

Fatty acid oxidation in AKI is 🔥🔥🔥No seats left @SunderSimsLucas

[Michael S. Balzer @ms_balzer]

Is fibrosis🐓or🥚? Fantastic talk in the spatial session by @Ina_M_Schiessl on intravital tracking of kidney tubules. #kidneyweek2024 #kidneyweek

[ninagoerlich @ninagoerlich]

Let’s go #kidneyweek2024 @ASNKidney @lfwgnr @P_Enghard @ms_balzer @Alibrandi_SA

[Michael S. Balzer @ms_balzer]

Congrats @AminAbedini1990 @KSusztak and team! 🔥🔥🔥

[Katalin Susztak @KSusztak]

🔥😀Super-super excited to report the publication of "Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression" in @NatureGenet https://t.co/2OeLBH6ese by @AminAbedini1990 and Jon Levinsohn #kidney #diabetes #spatial transcriptomics

[UKE Hamburg @UKEHamburg]

Prof. Dr. Tobias Huber aus dem #UKEHamburg ist vom @ERC_Research mit ERC Advanced Grant ausgezeichnet worden. Sein Forschungsprojekt zu einer Form der Nierenfilterschädigung (fokal segmentalen Glomerulosklerose, FSGS) wird mit 2,5 Mio. Euro gefördert: https://t.co/Va1tiSvM3s

[Michael S. Balzer @ms_balzer]

@UKEHamburg @Tobias_B_Huber @ERC_Research Congrats!

[JASN_News @JASN_News]

"The nephrology community has lost one of its truly remarkable figures..." Drs @JochenReiser and Martin Zeier remember the life and legacy of Eberhard Ritz https://t.co/pH4ixJrdS0

[Leonardo V. Riella @LVRiella]

With tremendous joy, I share that our patient who received a gene-edited pig kidney transplant was discharged home today after removal of his dialysis access. We hope that this is a first step that will bring hope to many patients waiting for a kidney transplant #xenotransplant

[evo-devo @Xiaojie_Qiu]

Thrilled to share that Dynamo v1.4 (https://t.co/dtIVWrIest) for single cell and metabolic labeling enabled RNA velocity vector field learning and prediction is now on PyPi! This is one of our biggest upgrades of Dynamo since early 2023. In this new release, we made the following extensive changes: 1) Implemented an interactive Shiny web application for in silico perturbation and least square action path analyses, see: https://t.co/4wnFBKPTZ7 2). More 3D plots with Plotly and Pyvista:
3D scatters with Plotly and Pyvista: - https://t.co/6Dx82vMNtI.scatters_interactive().
3D vectors with Plotly and Pyvista: -dyn.pl.cell_wise_vectors_3d().
3D topography with Plotly and Pyvista: - https://t.co/6Dx82vMNtI.topography_3d().
3D animation with Pyvista: https://t.co/kbzSxjBNQe.PyvistaAnim().
3). Extensive reorganization of the code in tools module: https://t.co/POBx0M6IpQ 4). Various tutorial updates and bug fixes are made. See our detailed release log here: https://t.co/HTW0tR6Iha In our next release, we are aiming to integrate Storm (https://t.co/BwYklhrg4G) and a few other new methods in our next releases. Stay tuned!

[Michael S. Balzer @ms_balzer]

@Hongbo919Liu @KSusztak Congrats, Hongbo! Way to go!

[Christoph Kuppe @KuppeChristoph]

🎉 Happy to share our first 📜 2024!🔬 Our review article in @GenomeMedicine on the innovative use of spatial multi-omics. Discover how these technologies are unlocking new understandings of cardiovascular disease. 🚀https://t.co/DjlEMgHeeD @UniklinikAachen @SpringerNature @RWTH

[Michael S. Balzer @ms_balzer]

Huge thank you 🙏to all involved: 👏@cetin_sz, Kathrien Abdank, @AminAbedini1990 @KSusztak Kai-Uwe Eckardt
@BIH_Innovation @EKFStiftung

Check out the 🔥paper in @NDTsocial: https://t.co/zQGrsg2NBZ

Eo/🧵

[Michael S. Balzer @ms_balzer]

❓❓❓Ever wondered how well pre-clinical #kidneydisease models translate to the human?

Recent #singlecell work led by top students in my lab, Kathrien Abdank & @cetin_sz, provides answers.

1/🧵

[Michael S. Balzer @ms_balzer]

CONCLUSION: our straightforward analytical framework
✅effectively positioned pre-clinical models along human biology (AKI-to-CKD);
✅showcased robust biological pathway concordance across species;
✅identified problematic datasets and samples.

6/🧵